This is Europe's largest and longest running early clinical development conference – 50 speakers and in its 10th year.
The only event to look at biomarkers, pharmacology, QT and imaging as well as discussing the relevant regulations.
Only Phase I event to encompass strategic, technological and operational areas.
The only event to look at biomarkers, pharmacology, QT and imaging as well as discussing the relevant regulations.
Only Phase I event to encompass strategic, technological and operational areas.
